Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,513,420.00 in Stock

United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm's stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $580.36, for a total transaction of $5,513,420.00. Following the completion of the transaction, the chief executive officer owned 40,513